Cellebrite DI Ltd. Global Chief Revenue Officer Marcus Jewell filed a Form 144 on November 10, 2026, notifying the SEC of a proposed sale of 1,045 ordinary shares on approximately November 12, 2026, following the vesting of restricted share units.
Cellebrite DI Ltd. officer David Gee filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 5,673 ordinary shares with an approximate date of sale of November 23, 2026.
Canaan Inc. (NASDAQ:CAN) released unaudited financial results for the three months ended September 30, 2026, disclosing total revenues of US$14.5 million, a 1,875 BTC cryptocurrency treasury, and a conditional grid connection classification for its 1 GW Duval County, Texas power project.
Embraer S.A. released its third quarter 2026 earnings results on November 10, 2026, reporting record third-quarter revenue and raising its full-year revenue and free cash flow guidance.
MBX Biosciences, Inc. filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 9, 2026, registering 900,000 shares of common stock issuable under its 2026 Inducement Plan.
Bicara Therapeutics Inc. filed a Form S-8 registration statement with the SEC on November 9, 2026, registering an additional 250,000 shares of common stock under its 2026 Inducement Plan, as amended.
ADC Therapeutics SA filed a Form S-3 registration statement with the SEC on November 9, 2026, to register 61,000,000 common shares for resale by selling shareholders who acquired the securities through securities purchase agreements dated October 7, 2026.
Trilogy Metals Inc. filed a Form S-3 registration statement with the SEC on November 10, 2026, covering the resale of up to 28,754,496 common shares held by or issuable to a Selling Shareholder.
Gregory S. Meyer filed a definitive proxy statement on November 10, 2026, soliciting shareholder support for his election to the Board of Directors of Vail Resorts, Inc. at the company's 2026 Annual Meeting scheduled for December 14, 2026.
CKX Lands, Inc. filed a Form 8-K on November 10, 2026, disclosing that on November 8, 2026, the company entered into an Investment Agreement with Jacobs Private Equity II, LLC and other investors providing for an aggregate cash investment of $1,000,000,000 in the company.